Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001218695 | SCV001390590 | uncertain significance | Imerslund-Grasbeck syndrome | 2022-04-01 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 947587). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with CUBN-related conditions. This variant is present in population databases (rs565917798, gnomAD 0.009%). This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 2460 of the CUBN protein (p.Ile2460Val). |
Fulgent Genetics, |
RCV002491680 | SCV002791621 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2022-04-15 | criteria provided, single submitter | clinical testing |